Bcl3 is a member of the IκB family that regulates genes involved in cell proliferation and apoptosis. Recent reports indicated that Bcl3 is overexpressed in HTLV-1-infected T cells via Tax-mediated transactivation, and acts as a negative regulator of viral transcription. However, the role of Bcl3 in cellular signal transduction and the growth of HTLV-1-infected T cells have not been reported. In this study, we showed that the knockdown of Bcl3 by short hairpin RNA inhibited the growth of HTLV-1-infected T cells. Although phosphatidylinositol-3 kinase (PI3K) inhibitor reduced Bcl3 expression, inactivation of glycogen synthase kinase 3 (GSK3), an effector kinase of the PI3K/Akt signaling pathway, restored Bcl3 expression in Tax-negative but not in Taxpositive T cells. Our results indicate that the overexpression of Bcl3 in HTLV-1-infected T cells is regulated not only by transcriptional but also by post-transcriptional mechanisms, and is involved in overgrowth of HTLV-1-infected T cells.
Introduction
Human T cell leukemia virus type 1 (HTLV-1) (Poiesz et al., 1980; Yoshida et al., 1982) is an exogenous human retrovirus that causes two distinct types of disease: adult T cell leukemia (ATL) (Hinuma et al., 1981; Yoshida et al., 1984) and HTLV-1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (Gessain et al., 1985; Osame et al., 1986) . ATL is an aggressive form of leukemia characterized by the malignant proliferation of CD4 + T cells infected with HTLV-1, whereas HAM/TSP is a chronic progressive myelopathy characterized by spastic paraparesis, sphincter dysfunction and mild sensory disturbance in the lower extremities (Nakagawa et al., 1995) . HTLV-1 encodes a number of regulatory proteins, i.e. Tax and Rex, as well as accessory proteins, i.e. p12, p13, p30 and HBZ, which participate in the life cycle of the virus (Matsuoka and Jeang, 2007) . Of these proteins, the viral oncoprotein Tax has been well characterized as a critical player in both viral and cellular transcription as well as malignant transformation. Tax is a transcriptional activator required for efficient expression of the viral genome through three conserved cyclic AMP response elements (CREs) located in the transcriptional control region of the virus, and also activates a variety of intracellular signal transduction pathways and subsequently deregulates gene expression though interaction with many different cellular proteins, including several transcription factors such as cAMP response element binding protein (CREB), NF-κB, serum response factor (SRF), and the transcriptional inhibitor, IκB (Yoshida, 2001 ). B-cell leukemia protein 3 (Bcl3) is a member of the IκB family initially identified as a putative proto-oncogene from chronic B-cell lymphocytic leukemia (McKeithan et al., 1987; Ohno et al., 1990) . Increased Bcl3 expression typically results from chromosomal translocations and leads to increased cell survival, proliferation, and malignancy (Courtois and Gilmore, 2006; McKeithan et al., 1987; Ohno et al., 1990) potential tomorigenesis in many cell types including T cells (Palmer and Chen, 2008) . Furthermore, it has been reported that respiratory syncytial virus (RSV) infection (Jamaluddin et al., 2005) and viral oncogenic proteins such as Epstein-Barr virus (EBV) latent membrane protein (LMP) (Kung and Raab-Traub, 2008; Nakamura et al., 2008) and Hepatitis B virus X protein (HBX) (Park et al., 2006) upregulate Bcl3 gene expression through activation of the NF-κB signaling pathway. In addition to its possible role in oncogenesis, recent reports also suggest that Bcl3 has an important function in controlling inflammation and autoimmunity mediated by the NF-κB signaling pathway (Schwarz et al., 1997) . Namely, Bcl3-deficient mice display defects in secondary lymphoid organs including partial loss of B cells (Franzoso et al., 1997) , exhibit severe defects in humoral immune responses, and in protection from in vivo pathogenic challenges (Schwarz et al., 1997) , and an autoimmune disease-like phenotype including uncontrolled inflammation mediated by aberrant inflammatory cytokine production (Carmody et al., 2007) . Bcl3-deficient cells derived from Bcl3-deficient mice are hypersensitive to toll like receptor (TLR) activation and are unable to control responses to lipopolysaccharides because of the absence of the normal Bcl3-mediated blockade of NF-κB p50 degradation (Carmody et al., 2007) .
These observations, especially overexpression of Bcl3 in a number of cancers including T cell leukemias, prompted us to investigate the roles of Bcl3 in HTLV-1 infection. In this study, we therefore focus on the molecular mechanism of Bcl3 protein overexpression in HTLV-1 infection and its effect on overgrowth of HTLV-1 infected cells, which may help to generate potential strategies for therapy of ATL.
Results

Bcl3 protein is constitutively expressed in HTLV-1-infected T cell lines
Although recent reports indicated that bcl3 mRNA is induced by HTLV-1 Tax oncoprotein (Hishiki et al., 2007) , there is no report whether Bcl-3 protein is also highly expressed and induced by Tax in HTLV-1 infected cells. We therefore first analyzed both bcl3 mRNA and protein expression in six HTLV-1-infected and three uninfected human T cell lines by RT-PCR and Western blot analysis. Bcl3 mRNA was expressed in all the six HTLV-infected T cell lines including MT-1, C5/MJ, HUT102 and MT-4 cells, all of which are not previously tested (Hishiki et al., 2007) , but not in all the three HTLV-1-uninfected T cell lines tested (Fig. 1A) . Similarly, Bcl3 protein was expressed in all the six HTLV-infected T cell lines, but not in all the three HTLV-1-uninfected T cell lines (Fig. 1B) . The Bcl3 protein was abundantly expressed in HUT-102, MT-2, and SLB-1 cells, which express high levels of Tax protein, whereas MT-1 cells, which do not express Tax protein, also express a low level of Bcl3 protein (Fig. 1B) . These data suggest that although the level of Bcl3 protein expression is largely dependent on the level of Tax protein expression in most HTLV-1-infected cell lines, Bcl3 protein expression is also maintained in MT-1 cells in a Tax-independent manner. Next, to examine whether Bcl3 protein expression is induced by Tax, we used JPX-9 cells, a Jurkat subclone generated by the stable introduction of a functional Tax expression-plasmid vector, and induced Tax expression by adding CdCl 2 into the culture medium (final concentration: 10 µM). Although bcl3 mRNA was already present before induction of Tax, both RT-PCR and Western blot analysis showed that Bcl3 expression was increased concomitantly with Tax in JPX-9 cells (Figs. 1C and D) .
Tax physically interacts with endogenous Bcl3 protein in human T cell lines naturally infected with HTLV-1
Although Kim et al. have recently demonstrated that Tax interacts with Bcl3 protein through the ankyrin repeat domain by using an in vitro GST-pull down assay and exogenous overexpression system in 293 T cells (Kim et al., 2008) , there is no report describing the interaction of Tax with Bcl3 in human T cells naturally infected with HTLV-1. We first confirmed the Bcl3 and Tax interaction by overexpression in 293 T cells. 293 T cells were transfected with pcDNA3-Bcl3 and/or pHβPr-1Tax1 and each lysate was divided into two. Each lysate was immunoprecipitated with anti-Bcl3 or anti-Tax antibody and subjected to Western blot analysis with anti-Tax or anti-Bcl3 antibody, respectively. As expected, Tax and Bcl3 proteins were immunoprecipitated with anti-Bcl3 or Tax antibody, but not with each control antibody ( Figs. 2A and B) . 1% aliquot of the lysates removed before immunoprecipitation was also analyzed by Western blotting with anti-Tax and anti-Bcl3 antibodies (Fig. 2C) . Next, we also investigated whether Tax physically interacts with endogenous Bcl3 protein in HTLV-1-infected T cells. The cell lysates of MT-2 and HUT102, which have high expression of Tax protein, were subjected to immunoprecipitation with anti-Bcl3 antibody, followed by Western blot analysis using anti-Tax antibody. As expected, Tax was immunoprecipitated with anti-Bcl3 antibody both in HUT102 ( Fig. 2D ) and MT-2 ( Fig. 2E ) cells, indicating that the physical interaction of Tax with Bcl3 protein is occur naturally in HTLV-1-infected T cells.
Suppression of Bcl3 protein expression inhibits cell growth of HTLV-1-infected T cell lines
It has been reported that the control of cell cycle progression is deregulated in HTLV-1 infected T cell lines (Akagi et al., 1996; Marriott and Semmes, 2005; Suzuki et al., 1996) . Also, Bcl3 has been shown to enhance cell cycle progression (Massoumi et al., 2006; Ohno et al., 1990; Rocha et al., 2003; Westerheide et al., 2001) . To examine the role of Bcl3 in the growth of HTLV-1-infected T cells, a lentivirusbased RNA interference system was used to knock down Bcl3 expression in three HTLV-1-infected T cell lines (HUT102, C5/MJ and MT-4). Lentiviruses encoding shRNA against Bcl3 together with a puromycin resistance gene were used to transduce each HTLV-1 infected T cell line, and the cells were cultured in the presence of puromycin for 2 days. Western blot analysis showed the suppression of Bcl3 protein expression with a Bcl3 shRNA virus, but not in those treated with a control virus (Fig. 3A) . Meanwhile, the cell growth was significantly inhibited in HUT102, C5/MJ and MT-4 cells infected with Bcl3 shRNA lentivirus as compared with those infected with the control lentivirus (Fig. 3B ). These results indicated the suppressive role of Bcl3 protein in the growth of HTLV-1-infected T cells.
The constitutive expression of Bcl3 protein is maintained by the posttranslational regulation through PI3K/Akt signaling pathway in HTLV-1-infected T cell lines
Since previous reports have shown that the activation of PI3K/Akt signaling pathway inhibits the Bcl3 protein degradation (Viatour et al., 2004) and PI3K/Akt signaling pathway is constitutively activated in HTLV-1-infected T cells (Ikezoe et al., 2007; Jeong et al., 2005; Tomita et al., 2006) , we examined whether overexpression of Bcl3 protein in HTLV-1-infected T cells is maintained by the posttranslational regulation via activation of PI3K/Akt signaling pathway, as well as the Tax-mediated transcriptional activation of Bcl3 gene (Hishiki et al., 2007; Kim et al., 2008) . Both Tax-negative HTLV-1-infected T cell line MT-1 and Tax-positive HTLV-1-infected T cell line MT-2 were treated with 20 µM of PI3K inhibitor LY294002 or its solvent DMSO for 6 h in the presence of 50 µg/ml cycloheximide (CHX) to block new protein synthesis. MG132, an inhibitor of 20 S proteasome mediated ubiquitin-dependent protein degradation, was used as a negative control of the Bcl3 protein degradation in the presence of CHX. In Tax-positive MT-2 cells, although Bcl3 protein expression was significantly reduced in the presence of 20 µM LY294002, such degradation was prevented by the MG132 treatment (Fig. 4A , the top). In contrast, Bcl3 protein expression was not significantly changed in the presence of 20 µM LY294002 but increased in the presence of 20 µM MG132 in Tax-negative MT-1 cells. Meanwhile, in Tax-positive MT-2 cells, phosphorylation of both Ser473 and Thr308 residues in Akt protein was inhibited by LY294002 (Fig. 4A , second and third from the top) whereas the Tax protein expression was not significantly changed by the LY294002 and MG132 treatments (Fig. 4A, fifth panel from the top) . In Tax-negative MT-1 cells, phosphorylation of both Ser473 and Thr308 residues in Akt protein was not detected. These data suggest that the overexpression of Bcl3 protein is maintained by the activation of PI3K/Akt signaling pathway in Tax-positive but not in Tax-negative HTLV-1 infected T cell lines.
Previous reports indicated that the glucose synthase kinase 3 (GSK3) mediates the Bcl3 protein degradation (Viatour et al., 2004) , and that GSK3 remains activated in Tax-negative HTLV-1-infected T cell line MT-1 but is fully inactivated in the Tax-positive HTLV-1-infected T cell line MT-2 (Tomita et al., 2006) . Therefore, to examine the effect of Tax for the Bcl3 protein degradation, we compared the degree of Bcl3 protein degradation mediated by GSK3 between Taxnegative MT-1 and Tax-positive MT-2 cells. When the cells were treated by lithium chloride (LiCl), which acts as a specific inhibitor of GSK3, we observed the accumulation of Bcl3 protein in Tax-negative MT-1 cells in a time-dependent manner, whereas the level of Bcl3 protein was not significantly changed in the Tax-positive MT-2 cells (Fig. 4B, top panel) . These results indicated that LiCl increases Bcl3 protein levels in cells with activated GSK3, but not in cells with inactive GSK3, because of constitutive activation of PI3K/Akt signaling pathway by Tax (Fig. 5 ).
Discussion
Recently, Hishiki et al. reported that bcl3 mRNA is constitutively expressed in three HTLV-1 infected T cell lines (MT-2, C91-PL and SLB-1) but not in two HTLV-1-uninfected human leukemic T cell lines (Jurkat and JPX-9). They also reported that bcl3 mRNA expression was induced in JPX-9 cell line treated with CdCl 2 along with the induction of viral transactivator Tax (Hishiki et al., 2007) . Since one NF-κB site within intron 2 acts as a transcriptional enhancer of Bcl3 gene in Jurkat T cells stimulated with phorbol myristate acetate (PMA) and ionomycin, which is mimicking T cell receptor activation (Ge et al., 2003) , it is likely that bcl3 overexpression is maintained by Tax-dependent mechanism. Indeed, Kim et al. have recently demonstrated that Tax mediates Bcl3 induction by intronic enhancers through activation of NF-κB signaling pathway in Jurkat T cells (Kim et al., 2008) . In this study, we first confirmed Bcl3 overexpression by using different cell lines both mRNA and protein levels. As expected, both Bcl3 mRNA and protein were overexpressed in five Tax-positive and one Tax-negative HTLV-1 infected T cell lines but not in three HTLV-1 uninfected T cell lines, and both Bcl3 mRNA and protein expression were induced along with the induction of Tax in JPX-9 cells.
The identification of Tax interacting proteins has been extensively performed, and numerous cellular proteins including transcriptional factors and cell signaling mediators have been reported (Sun and Yamaoka, 2005) . It is therefore believed that the interaction of Tax with those cellular proteins has critical roles in Tax-mediated cell immortalization and transformation as well as tomorigenesis (Giam and Jeang, 2007). Since previous study showed interaction between Tax and Bcl3 by artificial experimental systems employing overexpression in 293 T cells or GST-pull down assay (Kim et al., 2008) but not in human T cells naturally infected with HTLV-1, we demonstrated that Tax physically interacts with Bcl3 protein also in HTLV-1-infected T cell lines. It has been reported that the G1 to S transition in the cell cycle is enhanced by transcriptional upregulation of G1 cyclins including Cyclin D1 and D2 in HTLV-1 infected T cells (Neuveut and Jeang, 2002) , and the activation of NF-κB signaling pathway is critical for upregulation of those G1 cyclins and cell growth promotion in HTLV-1 infected T cells (Sun and Yamaoka, 2005) . Moreover, Mori et al. reported that both Cyclin D1 and D2 mRNAs were expressed at markedly higher levels in all HTLV-I-infected T cell lines (MT-2, MT-4, C5/MJ, SLB-1, and HUT102) than in any uninfected T cell lines (Jurkat, MOLT4, and CCRF-CEM), and Tax activated Cyclin D1 and D2 promoters mainly through NF-κB. Interestingly, expression of Cyclin D1 and D2 proteins concomitantly increased in JPX-9 cells after treatment with CdCl 2 , whereas the expression of Tax was not associated with any concomitant change in Cyclin D3 expression. Since Bcl3 has an important role in cell cycle progression by inducing Cyclin D1 gene expression (Westerheide et al., 2001) , and also in tumorigenesis through NF-κB signaling pathway (Courtois and Gilmore, 2006; Kerr et al., 1992; Massoumi et al., 2006; Ohno et al., 1990) , these observations suggest that constitutive expression of Bcl3 may promote cell cycle progression via upregulation of G1 cyclins through NF-κB signaling pathway in HTLV-1 infected T cells, although further studies are needed to clarify this point.
Previous report indicated that the GSK3-mediated Bcl3 protein degradation is induced by inhibition of de novo protein synthesis with cycloheximide (CHX), and this degradation is inhibited by the activation of PI3K/Akt signaling pathway in 293 T cells (Viatour et al., 2004) . On the other hand, previous report also indicated that Tax enhances the inactivation of GSK3 to inhibit β-catenin protein degradation through PI3K/Akt signaling pathway in HTLV-1-infected T cell line (Tomita et al., 2006) . We therefore compared the effects of PI3K/Akt inhibitor LY294002 and GSK3 inhibitor LiCl on both Taxnegative (MT-1) and Tax-positive (MT-2) HTLV-1 infected human T cell lines. As a result, consistent with these observations, our data indicated that PI3K/Akt inhibitor LY294002 induced the Bcl3 protein degradation in Tax-positive but not Tax-negative HTLV-1 infected T cell lines whereas treatment of GSK3 inhibitor LiCl enhanced the accumulation of Bcl3 protein in Tax-negative (i.e. GSK3 active) but not in Tax-positive (i.e. GSK3 inactive) HTLV-1-infected T cells. Namely, as well as the Tax-mediated transcriptional activation of Bcl3 gene (Hishiki et al., 2007; Kim et al., 2008) , overexpression of Bcl3 protein in HTLV-1-infected T cells is also maintained by the posttranslational regulation via inhibition of Bcl3 degradation through activation of PI3K/Akt signaling pathway and inactivation of GSK3 in Tax-positive but not Tax-negative HTLV-1-infected T cells. Since our data showed that the levels of Bcl3 protein in HTLV-1 infected T cells do not correlate with the expression levels of Tax protein, and a low level of Bcl3 protein was expressed also in Tax-negative MT-1 cells, Bcl3 protein expression is maintained in MT-1 cells in a Tax-independent manner. Recently, Kim et al. reported that Tax interacts with Bcl3 protein and that the ankyrin repeat domain is necessary and sufficient for inhibition of HTLV-1 LTR promoter activation (Kim et al., 2008) , whereas Hishiki et al. demonstrated that the interaction of Bcl3 with transducer of regulated CREB-binding proteins-3 (TORC-3) through the ankyrin repeat domain represses the transactivation of HTLV-1 LTR in a Tax-independent manner (Hishiki et al., 2007) . These results indicate that Bcl3 functions as a repressor of HTLV-1 LTR through the ankyrin repeat domain both in Tax-dependent and independent manners. In this study, we further showed that an overexpression of Bcl3 protein in HTLV-1-infected T cells is also maintained by the posttranslational regulation via inhibition of Bcl3 degradation through activation of PI3K/Akt signaling pathway and subsequent inactivation of GSK3 in Tax-positive HTLV-1-infected T cells. These data suggest that the mechanisms of Bcl3 upregulation and its stabilization are complex and different in each HTLV-1 infected T cell line, therefore the levels of Bcl3 protein do not simply correlate with the levels of Tax protein.
In summary, Bcl3 is constitutively expressed in HTLV-1 infected T cells by at least two Tax-mediated mechanisms, i.e. transactivation of Bcl3 gene expression (Kim et al., 2008) and posttranslational upregulation of Bcl3 protein through the activation of PI3K/Akt signaling pathway. Although the precise mechanism remains unclear, the interaction of Tax with Bcl3 may contribute to the formation of the ternary complex among Bcl3, coactivators and transcription factors, and thereby regulate the genes for cell cycle progression in HTLV-1 infected cells.
Materials and methods
Reagents
The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and 20 S proteasome inhibitor MG132 were purchased from Calbiochem (San Diego, CA). Cyclohexamide (CHX) was purchased from SigmaAldrich (St. Louis, MO). Lithium chloride (LiCl) and cadmium chloride (CdCl 2 ) were purchased from WAKO (Osaka, Japan).
Antibodies
Rabbit polyclonal anti-Bcl3 antibody (C-14) was purchased from Santa Cruz Biotechnology (San Diego, CA). Mouse monoclonal anti-GAPDH antibody was purchased from Millipore (Billerica, MA). Rabbit anti-Akt and anti-phosphorylated Akt (Ser473, Thr308) antibodies were purchased from Cell Signaling Technology (Beverly, MA). Mouse monoclonal anti-hemagglutinin (HA) antibody (HA-7) was purchased from Sigma-Aldrich (St. Louis, MO). Mouse monoclonal anti-Tax antibody (Lt-4) was kindly provided by Prof. Y. Tanaka (University of the Ryukyus, Okinawa, Japan).
Cell culture
Six HTLV-1 infected cell lines (C5/MJ, HUT-102, MT-1, MT-2, MT-4, and SLB-1) and three HTLV-1-uninfected T cell lines (CEM, MOLT-4, and Jurkat) were used in this study. MT-2, MT-4, C5/MJ, and SLB-1 cell lines are HTLV-1-transformed T cell lines established by an in vitro coculture protocol. MT-2, MT-4 and C5/MJ are umbilical cord blood T cell lines, whereas SLB-1 is an adult peripheral blood T cell line. HUT-102 was established from a patient with ATL, but it is unclear whether HUT-102 cells represent an actual tumor clone from the donor ATL patient. MT-1 is a leukemic T cell line derived from a patient with ATL. The Taxinducible JPX-9 cell line is a derivative of the Jurkat cell line, which expresses biologically active Tax protein under the control of the metallothionein promoter (Nagata et al., 1989) . These cells were cultured in RPMI 1640 medium supplemented with 10% heatinactivated fetal bovine serum (FBS), 50 U/ml penicillin, and 50 µg/ ml streptomycin (Wako) at 37°C in 5% CO 2 . 293 T cell is a human embryonic kidney cell line, and was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 2 mM L-glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin at 37°C in 5% CO 2 .
Reverse transcriptase PCR (RT-PCR)
Total cellular RNA was extracted from human leukemic T cell lines and HTLV-1-infected T cell lines by using RNeasy Mini Kit (QIAGEN, Tokyo, Japan) according to the manufacturer's instructions. Complementary DNA (cDNA) was synthesized using TaqMan Reverse Transcription kit (Applied Biosystems, Tokyo, Japan). For cDNA synthesis from extracted mRNA, 2 µg total RNA, 10 µl 10 × TaqMan RT buffer, 22 µl MgCl 2 (25 mM), 20 µl dNTPs mixture (at a final concentration of 500 µM each), 5 µl random hexamers (50 µM), 2 µl RNase inhibitor (20 U/µl), and 2.5 µl (50 U/µl) Moloney murine leukemia virus reverse transcriptase were added to a total volume of 100 µl. Samples were incubated at 25°C for 10 min and 48°C for 30 min, and reactions were stopped by heating to 95°C for 5 min. For amplification of cDNA fragments corresponding Bcl3, Tax, and GAPDH, 5 µl of cDNA solution were subjected to PCR amplification in a final volume of 50 µl containing 10pM of each oligonucleotide primer and 1× Premix Ex Taq (Takara Bio Inc., Shiga, Japan) in accordance with manufacturer's protocol. The oligonucleotide primers used were as follows: 5′-GAA AAC AAC AGC CTT AGC ATG GT-3′ (sense) and 5′-CTG CGG AGT ACA TTT GCG-3′ (antisense) for Bcl3; 5′-CGG ATA CCC AGT CTA CGT GT-3′ (sense) and 5′-GAG CCG ATA ACG CGT CCA TCG-3′ (antisense) for Tax; and 5′-TGG AAG TTG CTG TTG AAG TC-3′ (sense) and 5′-TCA AGA AGG TGG TGA AGC AG-3′ (antisense) for GAPDH. Amplified product sizes were 76 bp for Bcl3, 203 bp for Tax, and 100 bp for GAPDH. The amplification programs were as follows: 25 cycles of denaturing at 94°C for 30 s, an annealing step at 56°C for 60 s, and an extension step at 72°C for 90 s for Bcl3; 20 cycles of denaturing at 94°C for 30 s, an annealing step at 56°C for 60 s, and an extension step at 72°C for 90 s for Tax; and 20 cycles of denaturing at 94°C for 30 s, an annealing step at 56°C for 60 s, and an extension step at 72°C for 90 s for GAPDH. The PCR products were fractionated in 2.5% agarose gels and visualized by ethidium bromide staining.
Plasmids
Total cellular RNA was extracted from Jurkat cells and cDNA was synthesized as described above. The amplification of cDNA and constructions of expression plasmids for wild type Bcl3 were conducted as reported by Hishiki et al. (Hishiki et al., 2007) with minor modifications. For the amplification of cDNA encoding wild type human Bcl3, 5 µl of cDNA solution, 10pM of each oligonucleotide primer, 1x PCR buffer, 0.4 mM dNTPs, 1U of KOD-FX DNA polymerase (TOYOBO, Tokyo, Japan) were added to a total volume of 50 µl. The amplification programs were as follows: 1 cycle of denaturating at 94°C for 2 min, and then 30 cycles of denaturing at 98°C for 10 s, annealing and extension steps at 68°C for 60 s. The sequences of oligonucleotides primers are follows (lowercase letters indicate a linker sequence containing EcoRI and XhoI sites, respectively): 5′-aaa gaa ttc ATG GAC GAG GGG CCC GTG GAC-3′ and 5′-aaa ctc gag TCA GCT GCC TCC TGG AGC TGG-3′. The amplified product encoding wild type human Bcl3 was inserted into the EcoRI and XhoI sites of the pcDNA3 (Invitrogen). Tax expression vector pHβPr-1-neo-Tax1 and the empty vector were kindly provided by Prof. M. Fujii (Niigata University, Niigata, Japan).
Western blot analysis
Cells were lysed in sodium dodecyl sulfate (SDS) sample buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% (wt/vol) SDS, 10% glycerol, 6% 2-mercaptoethanol, and 0.01% bromophenol blue. The lysates were resolved by electrophoresis on polyacrylamide gels containing 0.1% SDS (SDS-PAGE) and then electroblotted onto nitrocellulose membranes (Amersham Biosciences). Membranes were blocked with 5% skim milk in PBS containing 0.05% tween 20 (PBS-Tween) overnight at 4°C. The blots were exposed to the appropriate first antibody for 2 h and then washed with PBS-Tween five times. After being washed, the blots were exposed to the appropriate secondary antibody conjugated with horseradish peroxidase for 1 h at room temperature and then washed with PBSTween five times. The reaction products were visualized using enhanced chemiluminescence reagent (Amersham Biosciences) according to the manufacturer's instructions.
Lentiviral transduction of short hairpin RNA (shRNA)
Lentivirus-mediated short hairpin RNA (shRNA) was used to knockdown Bcl3 in HTLV-1 infected human T cells by the method reported by Saitoh et al. (Saitoh et al., 2008) . For production of lentiviruses, 5 × 10 5 293 T cells were plated in 6 cm-dish 24 h before transfection. Cells were transfected with 0.5 µg of lentiviral vectors expressing shRNA against human Bcl3 or control shRNA (SigmaAldrich) together with 5 µl of Mission Lentiviral Packaging Mix (Sigma-Aldrich), which containing vesicular stomatitis virus G protein and the minimal set of lentiviral genes required to generate the virion structural protein and packaging functions, by using Lipofectamine LTX (Invitrogen) according to the manufacture's protocol. Culture supernatants were collected 48 h after transfection and filtered. HTLV-1-infected HUT102 and C5/MJ cells were infected with these lentiviruses for 16 h in the presence of 8 µg/ml polybrene or remained uninfected as a control of parental cells. Then infected and uninfected cells were suspended in flesh RPMI1640 medium containing 10% FBS and further incubated for 48 h. After 48 h incubation, infected cells were cultured in RPMI1640 containing 10% FBS in the presence of 1 µg/ml puromycin for an additional 48 h, other than the control of parental cells. These two infectants and the control parental cells were subjected to Western blotting to confirm the suppression of endogenous Bcl3 protein expression. These two infectants and the control parental cells were also subjected to trypan blue exclusion assay for the cell growth analysis. The number of viable cells was determined every one day by counting trypan blueexcluding cells in a hemocytometer.
Immunoprecipitation assay
For co-immunoprecipitation assay, 1 × 10 6 293 T cells were plated in 6 cm-dishes in DMEM supplemented with 10% FBS 24 h before transfection. After exchange to flesh DMEM containing 10% FBS, cells were transfected with 1 µg of pcDNA3 encoding wild type Bcl3 (pcDNA3-Bcl3) and 1 µg of pHβPr-1Tax1-neo or empty vector using Lipofectamine LTX (Invitrogen) according to the manufacturer's instructions. The cells were lysed in radio immune precipitation (RIPA) buffer (50 mM Tris-HCl pH 8.0, 100 mM, NaCl, 1 mM EDTA, 0.5% Nonidet P-40) supplemented with a complete protease inhibitor cocktail (Calbiochem). After removal of cell debris by centrifugation, 1 µg of each appropriate antibody was added to lysate and mixed with a rotator for 16 h at 4°C. Antibody-protein mixtures were then mixed with 20 µl of protein G-Sepharose beads (Amersham Biosciences) with the rotator for 2 h. The beads were then washed three times with RIPA buffer and the immunoprecipitated proteins were resolved by SDS-PAGE and analyzed by Western blotting with anti-Bcl3 antibody (C-14) or anti-Tax monoclonal antibody (Lt-4). 1% of each lysate was also subjected to Western blot analysis with each appropriate antibody. For the immunoprecipitation of endogenous Tax protein in HTLV-1-infected T cell lines, the cell lysates were prepared from 2 × 10 7 cells and immunoprecipitated with the non-immune rabbit IgG or rabbit polyclonal anti-Bcl3 antibody (C-14), and subjected to Western blot analysis with the anti-Tax antibody (Lt-4).
Statistical analyses
Statistical significance was determined using the Student's t test (unpaired, two-tailed). We considered P b 0.05 as statistically significant.
